Thomas Niel

Thomas Niel

InvestorPlace Contributor

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

The 7 Most Undervalued High-Yield Stocks to Buy Now July 2023

By Thomas Niel, InvestorPlace Contributor

With undervalued high-yield stocks, their respective low valuations can provide downside protection in case of a dividend cut, and an additional way to generate returns (if they bridge the gap between trading price and underlying value).

AI Chip Craze: To Buy or Not to Buy NVDA Stock Now?

By Thomas Niel, InvestorPlace Contributor

Feel free to make up your own mind on NVDA stock, but I'm sticking to the sidelines, and focusing on growth opportunities where the situation has yet to get out of hand.

Hey, QS Stock Investors! Is there a QuantumScape Surprise Coming July 26?

By Thomas Niel, InvestorPlace Contributor

Be careful, but the opportunity to sell QS stock into strength at an even higher price could arrive between now and July 26.

Stocks to Avoid: How Intel Has Gone From Blue-Chip to High-Risk

By Thomas Niel, InvestorPlace Contributor

Those bullish on INTC stock are free to place their bets, but I'm betting that this foundry gamble will ultimately come up snake eyes.

Wall Street Says Buy These 7 Stocks, Don’t Listen

By Thomas Niel, InvestorPlace Contributor

A good example is with these seven stocks to avoid. While overwhelmingly lauded by Wall Street, there is a solid bear case to be made with each one.

7 Penny Stocks to Sell Before They Damage Your Portfolio

By Thomas Niel, InvestorPlace Contributor

As correction risk remains, selling penny stocks, especially more speculative names like these seven, seems to be the best move right now.

Why You Should Steer Clear of Intel Stock Ahead of (and After) Earnings

By Thomas Niel, InvestorPlace Contributor

With near-term positive surprises unlikely to outweigh longer-term issues, continue to hold off on INTC stock.

The Qualcomm Question: Why Is QCOM Stock Missing Out on AI Mania?

By Thomas Niel, InvestorPlace Contributor

Despite the negativity, AI still could increase the chances of a QCOM stock comeback. With this, any further weakness may be a buying opportunity.

7 Biotech Stocks to Sell in July

By Thomas Niel, InvestorPlace Contributor

Running the gamut from large to small, and from commercial stage to clinical stage, these are seven top biotech stocks to sell in July.

Why These 7 Stocks Are the Best Ways to Play Fintech Right Now

By Thomas Niel, InvestorPlace Contributor

Each one of these seven fintech stocks is a great way to add "future of finance" exposure to your portfolio.

Load More